[Reversible Parkinsonism and cognitive impairment following treatment with valproate].
Toribio-Díaz
M E
ME
Morera-Guitart
J
J
Palao-Duarte
S
S
D000368:Aged; D000927:Anticonvulsants / Q000009:adverse effects*; D003072:Cognition Disorders / Q000139:chemically induced*; D005260:Female; D006801:Humans; D009483:Neuropsychological Tests; D020734:Parkinsonian Disorders / Q000139:chemically induced*; D014635:Valproic Acid / Q000009:adverse effects*
D000927:Anticonvulsants; D014635:Valproic Acid
Parkinsonismo y deterioro cognitivo reversibles tras tratamiento con ácido valproico.